News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Petros Grivas: This is a product of teamwork for many years
Photo from Petros Grivas/X
Jan 5, 2024, 11:46

Petros Grivas: This is a product of teamwork for many years

Petros Grivas, Associate Professor at University of Washington, shared on X/Twitter:

“This is a product of teamwork for many years: investigator-initiated trial of nivolumab +/- lirilumab as neoadjuvant treatment in cisplatin-ineligible patients with MIBC! Vadim Koshkin was a fellow when we started!”

Visit the article website.
Source: Petros Grivas/X

cancer Cisplatin investigator-initiated trial lirilumab nivolumab OncoDaily Oncology Petros Grivas product of teamwork teamwork Vadim Koshkin
Special Coverage
Insight
Aug 31, 2024, 12:58
Eric Singhi: Our editorial in ASCO Daily News on the CHOICE-01 study
Blog
Aug 31, 2024, 12:55
Simple steps you can follow to reduce your cancer risk at any age by Arif Kamal - ACS
Insight
Aug 31, 2024, 12:49
New Insights on Psilocybin's Impact on the Human Brain by Joshua Siegel et al.
Blog
Aug 31, 2024, 12:46
Honoring Steve Abbott, Executive Director of Cincinnati Cancer Advisors
Blog
Aug 31, 2024, 11:09
Edward D. Esplin: Clinician Responses to Germline Genetic Testing in Prostate Cancer Management
Blog
Aug 31, 2024, 10:53
OncoInfluencers to Follow on Social Media: Dr. Fabio Ynoe de Moraes
Insight
Aug 31, 2024, 10:03
Myeloma Paper of the Day, August 31st, suggested by Robert Orlowski
Insight
Aug 31, 2024, 09:52
Article of the day, August 31st, suggested by the Immune Oncology Research Institute
Blog
Aug 31, 2024, 09:47
Christian Rolfo: Excellent educational experience at Swiss Oncology Summer School
Insight
Aug 31, 2024, 09:45
Piotr Wysocki: Older patients with mCRC receiving fluoropyrimidine+bevacizumab do not gain additional benefit from adding oxaliplatin
Blog
Aug 31, 2024, 09:41
Miriam Mutebi: Children's lives cut short by cancer is a tragedy we can't ignore
Insight
Aug 31, 2024, 09:08
Vivek Subbiah: Our commentary on Precision oncology across the ages